-
Panel discussion to explore stem cell-derived beta cell therapy for type 1 diabetes
Sanjoy Dutta, PhD, Jay Skyler, MD, and other panelists will share insights on advances in the use of manufactured islets and what it might take to achieve widespread clinical use.
-
New clinical trial results to debut daily in New Orleans
Investigators will present high-impact results for type 1 diabetes, type 2 diabetes, and obesity in several clinical trial sessions. Glucagon-like peptide-1 (GLP-1)-based therapies—including dual and triple agonists, oral agents, and longer acting formulations—will be a recurring topic.
-
Maximize your Scientific Sessions experience through engagement
Rita R. Kalyani, MD, MHS, the ADA’s Chief Scientific and Medical Officer, encourages participants in New Orleans to come ready to delve deeper into their core areas of expertise and to seize opportunities to explore new ideas.
-
Join the ADA in New Orleans for the 2026 Scientific Sessions
Experts from across the globe will convene to share the latest cutting-edge advances in diabetes research, prevention, and care June 5–8 as part of an education program featuring 200 sessions across 25 topic areas.
-
Expand your network within the diabetes community
Attendees of the 2026 Scientific Sessions will have several opportunities to engage with other diabetes professionals, starting with Friday evening’s Networking Reception.
-
Discover New Orleans during the Scientific Sessions
Let the good times roll! A rich cultural character, exceptional culinary landscape, and vibrant musical traditions await in the city known as The Big Easy.